The National HIV Nurses Association (NHIVNA) is the leading UK professional association representing nurses in HIV care. Founded in 1998, it is a well-established and highly respected organisation committed to providing excellence in the care of those living with and affected by HIV.

The Association aims to provide an academic and educational forum for the dissemination of original nursing research in the field of HIV/AIDS. In addition, NHIVNA aims to address the communication and support needs of these nurses to assist in the promotion of best practice in the care of people with HIV. The Charity's objects are to advance education amongst members of the nursing profession about good nursing practices and to promote improved standards of nursing care of patients with HIV. In addition, NHIVNA supports research into the promotion of HIV nursing skills and aims to publish the results of such research for the benefit of the public.

The current membership of the Association is almost 350, located across the UK and Ireland. Membership benefits include subscription to the key journal HIV Nursing, the NHIVNA newsletter and free attendance at NHIVNA Study Days. For more details on the benefits of membership and how to join, please go to the Membership page.

Seeking members' views

NHIVNA values its members and seeks to empower them by three means: Research, Education and Support. The Association would be very grateful for members' views on how existing activities can be developed and enhanced. Please send your comments or suggestions to the Secretariat on




Upcoming Events

20th Annual Conference of NHIVNA (Brighton 2018)

Venue: Holiday Inn Brighton Sea Front, Brighton, UK

The 20th Annual Conference of the National HIV Nurses Association (NHIVNA) will be held in Brighton from 28-29 June 2018.



Dolutegravir may cause birth defects, European Medicines Agency warns

Keith Alcorn | 2 days ago

Regulatory agencies in the United States and European Union have warned that women with HIV wh......MORE


PrEP approved for adolescents in US

Liz Highleyman | 2 days ago

The US Food and Drug Administration (FDA) last week approved Truvada pre-exposure prophylaxis ......MORE


High prevalence of menopausal symptoms in women living with HIV, but very few receive treatments for them

Roger Pebody | 6 days ago

Nine in ten women living with HIV aged 45 to 60 have hot flushes and other somatic symptoms of......MORE


Do fatigue and quality of life improve after hepatitis C is cured?

Keith Alcorn | 7 days ago

Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in......MORE